Related Experiment Video
Updated: Sep 29, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism
Takeshi Ono1, Makoto Inoue, M Harunor Rashid
1Department of Anesthesiology, Nagasaki University School of Medicine, Nagasaki, Japan
Abstract:
In this report, we demonstrated that peripheral application of very low dose (amol ranges) of morphine induced flexor response through a substance P (SP) release at the nociceptor endings in mice. The intraplantar (i.pl.) application of morphine produced flexor response in a dose-dependent manner from 0.1 to 1000amol. The mu-opioid receptor (MOP-R) agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) also produced dose-dependent flexor response in same dose ranges. Morphine-induced flexor responses were markedly inhibited by naloxone and D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr amide (CTOP) both MOP-R antagonists and by intrathecal injection of antisense oligodeoxynucleotide (AS-ODN) for MOP-R which is expected to reduce the receptor expression in sensory nerve endings. Prior incubation with capsaicin, a depletor of SP from polymodal C fibers and [(+)-(2S,3S)-(2-methoxybenzylamino)-2-phenylpiperidine] (CP-99994), a tachykinin 1 receptor antagonist, also blocked the morphine-induced flexor responses. Moreover, pertussis toxin (PTX) which inactivates G(alpha)(i/o); [(1-[6-([(17b)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino)hexyl]-1H-pyrrole-2,5-dione)] (U-73122), an inhibitor of phospholipase C (PLC); ethyleneglycol-bis(beta-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA), a Ca(2+) chelating agent; xestospongin C, a membrane-permeable inositol trisphosphate (InsP(3)) receptor antagonist inhibited the morphine-flexor responses. However, thapsigargin, a depletor of intracellular Ca(2+) concentration and diphenhydramine, a histamine (His) H1 receptor antagonist, were unable to block the morphine-induced flexor responses. These results suggest that extremely low doses of morphine can stimulate sensory nerve endings through activation of peripheral MOP-R and its downstream mechanisms include activation of PLC through a SP release from polymodal C fibers.
Insights
Peripheral morphine at extremely low doses activates sensory nerve endings via mu-opioid receptors (MOP-R), triggering substance P (SP) release and a flexor response in mice.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Peripheral administration of opioids can modulate pain pathways.
- The role of peripheral mu-opioid receptors (MOP-R) in mediating acute responses is not fully understood.
Purpose of the Study:
- To investigate the effects of very low-dose peripheral morphine on nociception in mice.
- To elucidate the underlying molecular mechanisms, including receptor involvement and downstream signaling pathways.
Main Methods:
- Intraplantar administration of morphine and agonists/antagonists in mice.
- Assessment of flexor responses as a measure of nociception.
- Pharmacological inhibition of MOP-R, substance P (SP) pathways, and intracellular signaling cascades.
Main Results:
- Very low doses (amol range) of peripheral morphine induced a dose-dependent flexor response.
- This response was mediated by peripheral MOP-R activation and subsequent SP release from nociceptor endings.
- Downstream signaling involved phospholipase C (PLC) activation and calcium mobilization.
Conclusions:
- Extremely low doses of peripheral morphine can activate sensory nerve endings via MOP-R.
- This activation triggers a cascade involving SP release and downstream signaling pathways, leading to a nociceptive response.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Nociception
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Pain

